|
|
||||||||
J Thorac Cardiovasc Surg 2004;127:193-202
© 2004 The American Association for Thoracic Surgery
Surgery for congenital heart disease |
a Division of Cardiovascular Surgery, Hospital San Donato, San Donato Milanese, Italy
b Division of Cardiovascular Surgery, Hospital Civico of Palermo, Palermo, Italy
Received for publication August 29, 2002; revisions received November 19, 2002; accepted for publication December 2, 2002.
* Address for reprints: Dr Abella, Divisione di Cardiochirurgia I, Istituto Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Italy
r_abella{at}hotmail.com
| Abstract |
|---|
|
|
|---|
METHODS AND RESULTS: Since 1998, 5 patients (median age 29.6 months) with pulmonary atresia, ventricular septal defect, and major aortopulmonary collateral arteries have undergone surgical correction, consisting of (1) exclusion of a descending thoracic aortic segment from which all major aortopulmonary collateral arteries originate, and (2) connection of this aortic segment to the native pulmonary artery using an interposition polytetrafluoroethylene conduit. The ventricular septal defect was closed in all patients, and the right ventricle was connected to the unifocalized pulmonary artery with a valved conduit. All patients survived the operation. Two patients required reexploration for postoperative bleeding. One patient remained on mechanical ventilation for 17 days due to a pulmonary infection. During follow-up (12-21 months), no patient required additional interventions. The postoperative right ventricular/left ventricular pressure ratio was 0.55 median. No significant stenosis within the reconstructed pulmonary circuit was identified. All patients remain free of symptoms, requiring no medications.
CONCLUSION: Intracardiac repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries can be accomplished by a midline 1-stage repair including complete unifocalization of all pulmonary blood supply without individual collateral anastomosis in selected patients. This approach offers a convenient and satisfactory surgical option.
An important physiologic factor that signifies a favorable outcome for these patients is postrepair peak right ventricular pressure, which indirectly reflects both the number of lung segments incorporated by unifocalization and the status of the pulmonary microvasculature within those segments.1,2
According to Reddy and colleagues,3 early 1-stage complete unifocalization offers the best chance of achieving most or all of these goals. Although early and intermediate survival has indeed been favorable with this treatment philosophy, the need for late reinterventions on the reconstructed pulmonary arteries has been disappointing, unfortunately.
Therefore, we have recently adopted a 1-stage complete unifocalization technique that eliminates the need for anastomosis of individual aortopulmonary collateral vessels. We present our experience with this approach in the first 5 patients.
| Methods |
|---|
|
|
|---|
|
|
|
|
Surgical technique
The mediastinum was entered through median sternotomy and a transsternal thoracotomy ipsilateral to the aortic arch. The pleural spaces were opened wide anterior to both phrenic nerves, and the lungs were partially lifted out of the pleural cavities. The descending aorta was dissected free in the posterior mediastinum; the origins of the MAPCAs were identified, dissected looped, and temporarily occluded during bypass. Cardiopulmonary bypass was established by means of aorta-bicaval cannulation and a left atrial vent. While the patient was cooled to 18°C, the lungs were continuously ventilated. The ascending aorta was crossclamped and blood cardioplegia was administered. A short period of cardiac arrest was used for transsection of the descending aortic segment containing the origins of all aortopulmonary collateral vessels. Continuity of the descending thoracic aorta was established by interposing a 10-mm PTFE conduit in 2 patients and a 12-mm conduit in 2 patients. A direct end-to-end anastomosis of the thoracic aorta was possible in 1 patient (Table 4 and Figure 2, A and B). The resected aortic segment containing all MAPCAs measured approximately 5 cm in all 5 patients. The excised descending aortic segment was sutured distally, and the proximal stoma was anastomosed to the native pulmonary artery with a 16-mm PTFE conduit in 3 patients, a 14-mm conduit in 1, and a 12-mm conduit in the fifth patient (Table 4 and Figure 3, A and B). At this point, cardiopulmonary bypass was restarted, and the intracardiac repair was carried out.
|
|
|
The aortic crossclamp was then released, and during rewarming a 16-mm porcine bioprosthetic valved conduit (Hancock; Medtronic, Inc, Minneapolis, Minn) was used in 3 patients and heterologous (bovine) valved conduits (VenPro, Irvine, Calif) in 2 patients (12 mm and 14 mm) to connect the right ventricle to the reconstructed neopulmonary arterial system (Table 4 and Figure 4, A and B). Median duration of cardiopulmonary bypass was 220 minutes (range 120-305 minutes). Average cardioplegic arrest time was 70 minutes (range 52-87 minutes). Median duration of circulatory arrest was 49 minutes (range 49-66 minutes). After weaning from cardiopulmonary bypass, right ventricular, pulmonary arterial, and left atrial pressures were measured continuously. An intraoperative transesophageal echocardiogram was obtained to ensure that there were no significant residual defects.
|
| Results |
|---|
|
|
|---|
Two patients required reexploration for postoperative bleeding from the interposition descending thoracic aortic PTFE conduit. The open sternotomy incision was closed within an average of 3 days (range 1-4 days).
Postoperative mechanical ventilatory support was required for an average of 5 days (range 3-17 days). One patient required mechanical ventilation for 17 days due to a Pseudomonas pneumonia. Dopamine (3-10
· kg-1 · min-1) was prescribed in the postoperative period for an average of 5 days. In addition, 2 patients required adrenaline (0.05
· kg-1 · min-1) on the first postoperative day for hemodynamic instability. One patient underwent cardiac catheterization 15 days after the unifocalization because of persistent hypoxic spells (saturation 85%). This study confirmed a satisfactory hemodynamic repair. The right ventricular/left ventricular pressure ratio was less than 0.6, and the reconstructed pulmonary circulation was free of stenosis. The hypoxic spells in this patient eventually resolved. Postoperative complications included bronchopneumonia in 1, prolonged episodes of bronchospasm in 1, bleeding in 2, and pleural effusion in 1. Third-degree atrioventricular block developed in 1 patient, which reverted to normal atrioventricular conduction on the 20th postoperative day.
The average stay in the intensive care unit was 10 days (range 5-25 days). Time to hospital discharge averaged 20 days (range 15-59 days).
A predischarge echocardiogram in all 5 patients revealed good right ventricular function; tricuspid regurgitation was moderate in 2 patients. All valved conduits, as well as the aortic conduits, were free of stenosis. There were also no other residual intracardiac defects. At discharge, in all patients the arterial oxygen saturations ranged from 95% to 100% (median 98%).
Clinical follow-up ranging from 12 to 21 months (median interval of 15.4 months) revealed that all patients were doing well and so far none required additional interventions.
Twelve months after repair, all patients underwent 2-dimensional echocardiography and cardiac catheterization to evaluate the new pulmonary circulation (Table 5).
|
|
|
The neo-pulmonary confluence created by anastomosis of both conduits, the valved conduit from the right ventricle, and the PTFE conduit from the descending thoracic aortic to the native pulmonary artery was without significant gradient in all 5 patients.
The descending thoracic aortic reconstruction was free of stenosis in all patients. In 1 patient (patient 4) a 15 mm Hg gradient was measured across the PTFE conduit, which seemed clinically insignificant (Figure 7).
|
|
| Discussion |
|---|
|
|
|---|
Since the concept of unifocalization of pulmonary collaterals as a preliminary step to repair in patients with PA, VSD, and MAPCAs was introduced by Haworth and Macartney12 in 1980, multiple-stage procedures have been proposed by various authors17-22 to repair these complex lesions. Puga and colleagues18 reported on 38 consecutive patients; Iyer and Mee19 described their experience with 58 patients over a 10-year period; and Sawatari and coworkers20 reviewed the results with 16 patients over a 6-year period. In general, the results of the majority of these multistage approaches were disappointing, mostly because of a high late morbidity and mortality.
Furthermore, most centers using the multistage approach excluded the very young child mostly because of the small size and the need for prosthetic grafts. In older patients, whenever direct vascular anastomosis was not possible, prosthetic grafts were used quite liberally. Unfortunately, late stenosis of these anastomoses of prosthetic grafts to small pulmonary arteries occurred quite frequently. Also, systemic arterial collaterals exposed to longer periods of systemic pressureincreased flow and shear stress tend to develop myointimal hyperplasia, leading eventually to irreversible pulmonary vascular obstructive lesions.
The concept of using the descending aortic segment containing the origins of aortopulmonary collateral vessel to incorporate in the pulmonary circulation without MAPCAs anastomosis has been proposed previously by several authors.23,24 Murphy and colleagues24, in 1978, reported on a patient (3 years 6 months old) with PA, VSD, and MAPCAs: the descending aorta just distal to the 3 major pulmonary collaterals was ligated, and the proximal stoma was anastomosed to the right ventricle with a valved conduit (18-mm conduit; Edwards Lifesciences, Irvine, Calif). The VSD was closed. In this technique the pulmonary arterial circulation was supplied only by MAPCAs. Results of this approach were not encouraging. This procedure was abandoned.
More recently, Reddy and colleagues1 introduced an aggressive and very appealing new approach consisting of very early (young infants) single-stage unifocalization and repair. This radical approach offers the theoretical advantages of (1) establishing a normal cardiovascular physiology early in life, (2) eliminating the need for systemicpulmonary artery shunts, (3) use of prosthetic materials, and (4) decreasing the number of required operations. Furthermore, it should also protect against the development of pulmonary vascular obstructive lesions, whether through collaterals or systemic shunts. It remains to be seen whether the natural tendency of late collateral stenosis may be averted by early normalization of hemodynamics.1 Several other centers have recently reported results with their initial experiences with 1-stage unifocalization.2-25
In 2000, Reddy and colleagues3 reported a 10.6% early mortality and an 80% 3-year survival in an initial group of 89 patients. Considering the complexities of this lesion, the early and intermediate survival was indeed impressive. However, it was disappointing that 24 of the surviving patients required 36 reinterventions on the unifocalized pulmonary arteries; hence, intervention-free survival was only 42% at 5 years.3
In the 1-stage early unifocalization technique, emphasis is placed on avoiding the use of synthetic or allograft conduits, insisting on native tissue-to-tissue anastomosis. In neonates, surgical exposure, mobilization, and anastomosis of these collateral vessels and their corresponding pulmonary arteries can prove technically quite demanding, which could also introduce some additional technical factors that contribute to the need for late reinterventions.
Unfortunately, both the multistage or the early 1-stage unifocalization approaches have not proven entirely satisfactory.
The major advantage of the technique used in our 5 patients is the avoidance of small-vessel anastomosis, which should theoretically avoid late stenosis of either the native pulmonary arteries or of the MAPCAs.
Also, by early exposure of all aortopulmonary collaterals to a normal pulmonary artery pressure and flow, one should (theoretically) be able to anticipate avoidance of late intimal and medial pulmonary vascular pathologic changes.
Understanding of the pathophysiologic of these collateral arteries is increasing.6,10-12 Pulsatile stress and hypoxia and hyperoxia seem to first cause disruption of the elastic lamina and smooth muscle cell migration, which eventually leads to obstruction.26 According to Rabinovitch,27 the pathology of the narrowed collateral arteries resembles that of a normally closing ductus arteriosus. On the basis of these and other considerations, it seems that collateral artery disease is primarily a hemodynamic consequence rather than an intrinsic tendency of collateral vessels.27
Another important issue relates to the origins of MAPCAs in this disease. The great majority of the MAPCAs seem to originate from the descending thoracic aorta, usually in the vicinity of the left main bronchus (left aortic arch) or close to the carina in the case of a right aortic arch.14,22,28 In fewer cases, the MAPCAs can originate from a common aortic trunk arising from the ascending thoracic aorta; occasionally, a large left or right MAPCA may cross over to the contralateral lung.29 Finally, MAPCAs can also originate from branches of the aorta (indirect origin) such as the left or right subclavian or internal thoracic arteries or, more rarely, even from the abdominal aorta or 1 of its branches. Obviously, in these circumstances the aortic segment technique is not applicable.
The need to use prosthetic grafts in these patients with the possibility of developing stenosis remains a worrisome feature of this approach. Management of this late complication could involve reoperation in several patients. At present, procedures are undergoing with optimal results, but undoubtedly this complication may increase the morbidity in this cohort of patients in the future.
This aortic segment technique in our limited experience should be used in patients without collateral stenosis and MAPCAs originating from the descending thoracic aorta. Certainly, our selected cohort is not representative of the overall population of individuals born with this anomaly. The use of this approach combined with direct tissue-to-tissue anastomoses in selected patients or the help of catheter interventional techniques (balloon dilatation stenting or both) could (theoretically) be the solution to widespread application of this technique and could attempt to decrease the age of elective repair.
Clearly, the follow-up period of 12 to 21 months is too short a time span to permit a final judgment concerning the long-term fate of the unifocalized collaterals.
Limitations of this study
More patients and a longer follow-up period are necessary to allow more definitive conclusions about the aortic segment technique.
| Conclusions |
|---|
|
|
|---|
This approach offers a convenient surgical option in selected patients, providing a low early risk and optimal intermediate results.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Dragulescu, I. Kammache, V. Fouilloux, P. Amedro, D. Metras, B. Kreitmann, and A. Fraisse Long-term results of pulmonary artery rehabilitation in patients with pulmonary atresia, ventricular septal defect, pulmonary artery hypoplasia, and major aortopulmonary collaterals J. Thorac. Cardiovasc. Surg., December 1, 2011; 142(6): 1374 - 1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Januszewska, E. Malec, G. Juchem, I. Kaczmarek, R. Sodian, P. Uberfuhr, and B. Reichart Heart-lung transplantation in patients with pulmonary atresia and ventricular septal defect J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 738 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Graham Jr The year in congenital heart disease J. Am. Coll. Cardiol., June 2, 2004; 43(11): 2132 - 2141. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |